SG Americas Securities
ARKG icon

SG Americas Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

SG Americas Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76K Sell
34,000
-20,000
-37% -$586K ﹤0.01% 2982
2025
Q4 		$215K Buy
54,000
+20,000
+59% +$600K ﹤0.01% 2898
2025
Q3 		$170K Hold
34,000
– – ﹤0.01% 2824
2025
Q2 		$146K Hold
34,000
– – ﹤0.01% 2439
2025
Q1 		$100K Hold
34,000
– – ﹤0.01% 3054
2024
Q4 		$160K Buy
+34,000
New +$837K ﹤0.01% 2353

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

SG Americas Securities's ARKG Position: Q1 2026 in Review

SG Americas Securities reduced its ARK Genomic Revolution ETF (ARKG) stake by 85% in Q1 2026, selling an estimated $2.54M and leaving 15,786 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #2285.

SG Americas Securities first reported a position in ARKG in Q1 2019 and has held it in 23 quarters since. The position peaked at $6.99M in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • SG Americas Securities held 15,786 shares of ARK Genomic Revolution ETF worth $417K as of Q1 2026.
  • SG Americas Securities sold 86,735 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $2.54M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2285 holding.
  • SG Americas Securities first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 23 quarters since.
  • SG Americas Securities's ARK Genomic Revolution ETF position peaked at $6.99M in Q4 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.